REQUEST A DEMO
Total
USD $0.00
Search more companies

Vitrosens Biyoteknoloji A.S. (Turkiye)

Main Activities: Testing Laboratories
Full name: Vitrosens Biyoteknoloji Anonim Sirketi Profile Updated: March 05, 2026
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Vitrosens Biyoteknoloji A.S. is an in-vitro diagnostics manufacturer focused on the development and production of rapid diagnostic testing solutions for human health and veterinary applications. The company operates across rapid test kit segments and point-of-care diagnostic systems, including fluorescence immunoassay platform solutions and related consumables, and provides a portfolio designed for fast and efficient testing workflows in professional healthcare environments. Vitrosens positions its manufacturing and R&D capabilities around innovation-led product development, quality management and regulatory-aligned production processes, supporting distribution of diagnostic products to domestic and international markets through partner and distributor channels. The companys strategic focus is centered on scalable diagnostics manufacturing, expansion of its product portfolio, and strengthening of global market presence with competitive, quality-assured testing solutions.

Headquarters
Sumak No:17a Serifali Mahallesi Sehit Sokak Umraniye
Istanbul; Marmara; Postal Code: 34775

Contact Details: Purchase the Vitrosens Biyoteknoloji A.S. report to view the information.

Website: http://www.vitrosens.com

Basic Information
Total Employees:
Purchase the Vitrosens Biyoteknoloji A.S. report to view the information.
Financial Auditors:
Purchase the Vitrosens Biyoteknoloji A.S. report to view the information.
Incorporation Date:
November 27, 2020
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Vitrosens Biyoteknoloji A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
-18.5%
Total operating revenue
-18.5%
Operating Profit/Loss (EBIT)
-68.84%
Net Profit/Loss for the Period
-31.67%
Total Assets
-30.24%
Total Equity
50.43%
Operating Profit Margin (ROS)
-16.99%
Net Profit Margin
-3.35%
Return on Equity (ROE)
-40.28%
Quick Ratio
1.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?